Janssen Pharmaceutica has inked a deal with the African Vaccine Acquisition Trust (AVAT) to supply up to 220 million doses of its single-shot COVID-19
Making A List Of Penny Stocks? 4 Energy Stocks To Watch Right Now
Are These 5 Penny Stocks On Your Buy List Right Now?
AstraZeneca has issued revised efficacy figures from the US trial of its COVID-19 vaccine following a complaint
Doubts emerge over AZ’s ‘outdated’ US vaccine trial data...
Fewer Europeans trust the AstraZeneca Covid-19 vaccine after several countries reported side effects, such as blood clots, an opinion poll by YouGov showed
Royal Caribbean International is taking a page from the airlines and implementing a COVID passport for all passengers and crew on their next sailing in the...
Powell Can't Raise Rates As Economy Remains On Life-Support
'Stimmy' Hangover? Stocks Sink As Fed Flubs, Bond Bull-Market Ends Dow and S&P 500 ended red after an ugly close, Small Caps were best...
The European Commission has announced plans to introduce a joint vaccination passport to facilitate free movement inside the EU during the COVID-19 pandemic.
China's Semiconductor Manufacturing International Corporation (SMIC) said it has entered into an agreement with the Shenzhen government to build a new wafer fabrication plant
GSK and Medicago’s plant-based COVID-19 shot heads into phase 3 trial
Sellers pushed Bitcoin price below $55,000 despite traders anticipating a $1,400 stimulus check rally.
A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2 but only 55% against the South African variant
The biotechnology market has caught fire as multiple companies rushed to produce a treatments to aid patients sick and dying from the COVID-19 pandemic.
EU's Countries Playing Politics With Russian Sputnik-V Vaccine
Novavax Covid-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the UK
The European Union’s drugs regulator approved Johnson & Johnson’s single dose COVID-19 vaccine
The United States plans to double the country's order of the single-shot J&J coronavirus vaccine
The rollout of the US COVID-19 vaccination program slowed up this week because J&J manufacturing delays meant no new supply.
Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study
Panasonic looks like it is getting into the software and the supply chain business.
Adaptive Biotechnologies’ T-Detect COVID diagnostic test, which was designed to confirm a recent or prior COVID-19 infection, has been approved by the US FDA
Psychedelic & Cannabis Stocks Are Surging As Investors Rally Behind Emerging Biotech Trends
The U.S. health regulator granted emergency use authorization for Abbott Laboratories' molecular test to detect and distinguish the coronavirus and two types of flu viruses with...
With EU countries breaking ranks in order to get access to the Russian Sputnik V COVID-19 vaccine, the EMA was forced into starting rolling review of...
Are These Hot Penny Stocks On Your List To Watch This Week? 5 Active Names To Watch This Week
Both the Pfizer/BioNTech and AstraZeneca/Oxford COVID-19 vaccines are highly effective in reducing COVID-19 infections among older people
There is still no cure for COVID-19, but doctors have several innovative treatments. Some are keeping patients out of the hospital entirely.
J&J's single-dose COVID-19 vaccine has been authorized for emergency use by the US FDA for the treatment of adults. Shares rose 1.6% in after-hours